<P>Canarium lyi C.D. Dai & Yakovlev (CL) is a member of the Anacardiaceae family: To the best of our knowledge, no studies on its anti-inflammatory effects have yet been reported. In the present study, we investigated the protective effects ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107542222
2015
-
SCI,SCIE,SCOPUS
학술저널
1403-1410(8쪽)
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
<P>Canarium lyi C.D. Dai & Yakovlev (CL) is a member of the Anacardiaceae family: To the best of our knowledge, no studies on its anti-inflammatory effects have yet been reported. In the present study, we investigated the protective effects ...
<P>Canarium lyi C.D. Dai & Yakovlev (CL) is a member of the Anacardiaceae family: To the best of our knowledge, no studies on its anti-inflammatory effects have yet been reported. In the present study, we investigated the protective effects of CL on inflammation in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells and LPS-induced acute lung injury (ALI) mice. CL attenuated the production of LPS-stimulated inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, and interleukin-6 (IL-6). Furthermore, CL suppressed phosphorylation of the inhibitor kappa B-alpha (I kappa B-alpha), p38, c-Jun terminal kinase (JNK) and extracellular signal-regulated kinase (ERK), as well as the translocation of the nuclear factor-kappa B (NF-kappa B) p65 subunit into the nucleus. For the in vivo efficacy, the effect of CL on a mouse model of LPS-induced acute lung injury was assessed. CL treatment of the mice significantly inhibited the inflammatory cell recruitment and pro-inflammatory cytokine production in bronchoalveolar lavage fluids (BALF). CL-treated mice also showed a marked inhibition of cyclooxygenase-2 (COX-2) and phosphorylation of I kappa B and p65. In addition, CL attenuated lung histopathological changes in LPS-induced ALT mice. In conclusion, our results suggest that CL is a potential therapeutic candidate for the treatment of inflammatory diseases, including pneumonia.</P>